Skip to main content
GlaxoSmithKline Pakistan Limited logo

GlaxoSmithKline Pakistan Limited — Investor Relations & Filings

Ticker · GLAXO ISIN · PK0001301016 PSX Manufacturing
Open in API
Filings indexed 241 across all filing types
Latest filing 2026-05-08 Report Publication Anno…
Country PK Pakistan
Listing PSX GLAXO

About GlaxoSmithKline Pakistan Limited

https://pk.gsk.com/en-pk/home/

GlaxoSmithKline Pakistan Limited is a focused biopharma company dedicated to the discovery, development, and delivery of innovative medicines and vaccines. Leveraging a science-led approach, its research and development efforts concentrate on critical therapeutic areas including respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. The company strives to create value for patients by providing high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Video Recording of the Corporate Briefing Session
Report Publication Announcement Classification · 82% confidence The document is a brief notice to the Pakistan Stock Exchange informing that the video recording of the company’s corporate briefing session (for the year ended Dec 31 2025) has been made available on the company website via a link. It contains no substantive financial data or presentation content itself, only a notice of where to find it. Under the “Report Publication Announcement” definition (announcement of the release or availability of a report/presentation), this is classified as RPA.
2026-05-08 English
Credit of Final Cash Dividend
Notice of Dividend Amount Classification · 92% confidence The document is a formal notice from GlaxoSmithKline Pakistan to the stock exchange informing shareholders of the final cash dividend amount (Rs. 12.00 per share) and its electronic credit date for the year ended December 31, 2025. This matches the definition of a Notice of Dividend Amount (DIV).
2026-05-06 English
Presentation of the Corporate Briefing Session
Investor Presentation Classification · 93% confidence The document is a slide deck entitled “Corporate Briefing Session 2026” by GSK Pakistan, containing an investor‐style presentation: company overview, economic outlook, financial outline with income statement, balance sheet, ratios, strategy and Q&A session. It is not an official annual or interim report filing but rather a presentation for investors. Therefore it matches the “Investor Presentation” category.
2026-05-05 English
Corporate Briefing Session
Regulatory Filings
2026-04-30 English
Certified True Copy of The Resolutions passed by the shareholders in the Annual General Meeting held on April 30, 2026
Regulatory Filings
2026-04-30 English
Transmission of Quarterly Financial Statements for the Period ended March 31, 2026
Regulatory Filings
2026-04-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.